Zentiva Group Overview
- Status
-
Private
- Employees
-
5,400
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
11
- Investments
-
12
Zentiva Group General Information
Description
Zentiva AS is engaged in the development, production, and distribution of generic medicines. It operates in more than 25 European markets. The company therapeutic areas inlcude Cardiovascular, Central nervous system, Gastrointestinal and metabolic disorders, Anti-inflammatory and pain, Ophthalmology, Anti-infectives, Urology, Respiratory, Blood disorders, and Oncology.
Contact Information
Website
www.zentiva.comCorporate Office
- U Kabelovny 529/16
- Dolní Měcholupy
- Prague, 102 00
- Czech Republic
Corporate Office
- U Kabelovny 529/16
- Dolní Měcholupy
- Prague, 102 00
- Czech Republic
Zentiva Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Zentiva Group Comparisons
Industry
Financing
Details
Zentiva Group Competitors (55)
One of Zentiva Group’s 55 competitors is Niche Generics, a Corporate Backed or Acquired company based in Arlesey, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Niche Generics | Corporate Backed or Acquired | Arlesey, United Kingdom | ||||
| Bluefish Pharmaceuticals | Private Equity-Backed | Stockholm, Sweden | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Chiesi Farmaceutici | Private Debt Financed | Parma, Italy |
Zentiva Group Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Zentiva Group Patents
Zentiva Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202418754-D0 | Method for producing (s)-amlodipine succinate | Pending | 19-Dec-2024 | ||
| WO-2026131988-A1 | Method for producing (s)-amlodipine succinate | Pending | 19-Dec-2024 | ||
| EP-4652989-A1 | Coated tenofovir alafenamide | Pending | 21-May-2024 | ||
| GB-202407194-D0 | Inactive | 21-May-2024 | |||
| EP-4649944-A1 | Pharmaceutical composition of alprazolam | Inactive | 13-May-2024 | A61K31/5517 |
Zentiva Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Zentiva Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Zentiva Group Investments & Acquisitions (12)
Zentiva Group’s most recent deal was a Buyout/LBO with Aboca (Five Heritage Brands). The deal was made on 30-Jun-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Aboca (Five Heritage Brands) | 30-Jun-2025 | Buyout/LBO | Pharmaceuticals | ||
| Apontis Pharma | 13-Jun-2025 | Secondary Transaction - Private | Pharmaceuticals | ||
| Apontis Pharma | 09-Dec-2024 | Buyout/LBO | Pharmaceuticals | ||
| Blokurima | 01-Nov-2024 | Buyout/LBO | Other Consumer Non-Durables | ||
| Sanofi (Zerinol and Schoum Solution) | 06-Dec-2022 | Buyout/LBO | Pharmaceuticals |
Zentiva Group Exits (2)
Zentiva Group’s most recent exit was on 01-Jan-2007 from Sanofi (Lüleburgaz Manufacturing Plant in Luleburgaz, Turkey). The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Sanofi (Lüleburgaz Manufacturing Plant in Luleburgaz, Turkey) | 01-Jan-2007 | Completed |
|
||
| Saneca Pharmaceuticals | 11-Aug-2003 | Buyout/LBO | Completed |
|
Zentiva Group Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Apontis Pharma | Monheim am Rhein, Germany | 1946 | |
| Blokurima | Prague, Czech Republic |
Zentiva Group FAQs
-
Where is Zentiva Group headquartered?
Zentiva Group is headquartered in Prague, Czech Republic.
-
What is the size of Zentiva Group?
Zentiva Group has 5,400 total employees.
-
What industry is Zentiva Group in?
Zentiva Group’s primary industry is Pharmaceuticals.
-
Is Zentiva Group a private or public company?
Zentiva Group is a Private company.
-
What is the current valuation of Zentiva Group?
The current valuation of Zentiva Group is .
-
What is Zentiva Group’s current revenue?
The current revenue for Zentiva Group is .
-
How much funding has Zentiva Group raised over time?
Zentiva Group has raised $4.12B.
-
Who are Zentiva Group’s investors?
CPP Investments, FS KKR Capital BDC, and GTCR have invested in Zentiva Group.
-
Who are Zentiva Group’s competitors?
Niche Generics, Bluefish Pharmaceuticals, Glenmark Pharmaceuticals, Pfizer (Vienna), and Chiesi Farmaceutici are some of the 55 competitors of Zentiva Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
